Blueprint
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For
period ending 29 March
2018
GlaxoSmithKline plc
(Name
of registrant)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or
will
file annual reports under cover Form 20-F or Form 40-F
Form
20-F x Form 40-F
--
Indicate
by check mark whether the registrant by furnishing the
information
contained in this Form is also thereby furnishing the
information
to the Commission pursuant to Rule 12g3-2(b) under the
Securities
Exchange Act of 1934.
Yes
No x
GlaxoSmithKline
plc
(the 'Company')
Publication of 2018 Notice of Annual General Meeting
The Company will today publish on its website, www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting,
the 2018 Notice of Annual General Meeting (the '2018 AGM Notice'),
together with the 2017 Annual Summary.
The
Company's Annual General Meeting will be held on Thursday 3 May
2018 at 2.30 pm at the QEII Centre, Broad Sanctuary, Westminster,
London SW1P 3EE.
The
2018 AGM Notice, together with the 2017 Annual Report and 2017
Annual Summary, will today be sent to those shareholders who have
elected to receive paper communications.
In compliance with Listing Rule 9.6.1R of the UK Financial Conduct
Authority, the 2018 AGM Notice and 2017 Annual Summary will be
submitted to the UK Listing Authority and will, in due course, be
available for inspection at www.morningstar.co.uk/uk/NSM.
V A Whyte
Company Secretary
29
March 2018
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: March
29, 2018
|
|
|
|
|
By: VICTORIA
WHYTE
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|